Clinical trial
Evaluation and Treatment of Severe Acute Respiratory Syndrome (SARS)
NCT00073086 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Withdrawn
Key facts
| NCT number | NCT00073086 |
|---|---|
| Title | Evaluation and Treatment of Severe Acute Respiratory Syndrome (SARS) |
| Official title | Clinical Evaluation and Management of Persons With Severe Acute Respiratory Syndrome (SARS) |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Severe Acute Respiratory Syndrome |
| Enrollment | 0 |
| Start date | Nov 5, 2003 |
| Completion | Dec 27, 2010 |
| First posted | Nov 17, 2003 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: